Amneal (AMRX) traded flat 0 % during a 24 hours period ending at 03:25 PM Central Europe on Monday 26th. One Amneal stock can currently be bought for about USD 21.1 on popular exchanges. Current supply of Amneal stocks is 348.4 mn. Amneal has a current market capitalization of USD 7.1 bn and approximately USD 100.4 mn worth of Amneal was traded on exchanges in the last 24 hours. Since last month end, Amneal has traded 2.9 % up. Simple moving average of last 200 days is at USD 17.91. The highest price of past 52 weeks was recorded at USD 21.18 on 09/21/2026. 52 weeks low was at USD 9.99 on 10/30/2025.

Here is how related stocks have performed in the past 24 hours:

  • Morningstar (MORN) traded up 0.7 % and now trades at USD 226.1. Current market capitalisation for Morningstar is USD 8.4 bn. Morningstar has a current price to earnings ratio of 21.37.

  • Cytokinetics (CYTK) traded down -1.76 % and now trades at USD 61.63. Current market capitalisation for Cytokinetics is USD 8.5 bn.

  • Mohawk Industries (MHK) traded down -3.09 % and now trades at USD 124.07. Current market capitalisation for Mohawk Industries is USD 8.4 bn. Mohawk Industries has a current price to earnings ratio of 16.58.

  • Spyre Therapeutics (SYRE) traded down -2.17 % and now trades at USD 93.2. Spyre Therapeutics has a market capitalisation of USD 8.4 bn.

  • Viasat (VSAT) traded up 4.19 % and now trades at USD 63.6. Current market capitalisation for Viasat is USD 8.5 bn. Maritime navigation faces growing interference, prompting heightened reliance on satellite communications. Viasat, a provider of broadband and defence‑focused services, competes with Iridium’s low‑Earth‑orbit network, both striving to deliver resilient connectivity amid increasing GPS jamming and spoofing. The sector’s demand for robust, low‑bandwidth solutions has spurred interest in software innovations that can transmit essential data even when network capacity is strained. Viasat’s positioning within the defence market underscores its role in supporting secure communications for military and commercial vessels operating in contested regions. Recent market activity reflects this shift, with investors closely watching developments that enhance the reliability and affordability of satellite links in an environment of rising electronic warfare challenges.

About Amneal

Amneal Pharmaceuticals, Inc. is a pharmaceutical company that specializes in supplying medical products for central nervous system disorders, parasitic infections, and other therapeutic categories. They serve the global healthcare sector. You can find more information about them on their website, www.amneal.com , and they are listed on the New York Stock Exchange.